Volume 22, Number 7—July 2016
Synopsis
Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013–2014
Table 2
Disease severity | No. samples | No. (%) positive LRT samples |
No. (%) positive URT samples |
|||
---|---|---|---|---|---|---|
<14 d | ≥14 d | <14 d | ≥14 d | |||
Severely symptomatic | 67 | 23 (34) | 26 (39) | 13 (19) | 5 (8) | |
Mildly symptomatic | 148 | 81 (55) | 54 (37) | 12 (8) | 1 (1) | |
Asymptomatic |
82 |
60 (73) |
5 (6)† |
17 (21) |
0 |
|
Total | 297 | 164 (55) | 85 (29) | 42 (14) | 6 (2) |
*Percentages might not sum to 100% due to rounding. LRT, lower respiratory tract; MERS-CoV, Middle East respiratory syndrome coronavirus; rRT-PCR, real-time reverse transcription PCR; URT, upper respiratory tract.
†All 5 lower respiratory samples that were positive for ≥14 d were from 1 asymptomatic case-patient.
1These authors contributed equally to this article and share first authorship.
Page created: June 14, 2016
Page updated: June 14, 2016
Page reviewed: June 14, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.